What Stocks To Buy as Markets Hit Another Record High?

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

Another day, another dollar profit. The S&P 500 Index (INDEXSP: .INX) has hit another record high close. But as the tide is rising all floating boats, what are the best stocks to buy? Are there any you should avoid?

There is immense optimism in markets as the presidency transition looks to be peaceful, COVID vaccines are here, trade wars are over, and like winter… Stimulus is coming!

At these record-high levels, it’s almost hard to hit the buy button. The only fear of such an upside is if the rug is pulled out beneath our feet, there could be a hard fall from grace. But, we don’t foresee any near-term catalyst for such capitulation.

Watch the full interview to see the “junk retailers” Lance is betting on this holiday season, why precious metals are a better safe haven than banks, and if there will ever be a rotation out of the tech giants.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.